Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.
By R. Mattick, C. Breen, J. Kimber, M. Davoli, R. Breen. Cochrane Database of Systematic Reviews, 2003
1,293 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/119e4edd81b0738631093848ec72ff6a7c7a645a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- D. Tauben
Citations in the corpus
- CDC guideline for prescribing opioids for chronic pain (2016, background): “Opioid agonist treatment with buprenorphine or methadone maintenance therapy in combination with behavioral therapies has been demonstrated to be more effective in preventing relapse among patients with opioid use disorder than detoxification without maintenance medication (164, 165).”
- Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure (2010, unknown): “Any serious adverse event 14 (16) 8 (9) 6 (8) 1 (2)”
- Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality (2018, unknown): “Long-term 1284 (7) 668 (5) 148 (10) 207 (9) 127 (16) 134 (16)”